An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone on Reddit posted that they've been on a 1.7 mg dose of Wegovy (a prescription weight-loss drug) for a few months and lately feel like they're "just eating everything again." They haven't regained weight, but they also haven't continued losing it, and they're wondering whether it's time to increase the dose. That’s the everyday question behind a short forum post. Wegovy is the brand name for the drug semaglutide at a specific dose and schedule. Semaglutide is a medication that mimics a natural gut hormone that helps you feel full and slows how quickly your stomach empties. Doctors give it as a weekly injection for chronic weight management alongside diet and exercise. It does not make food taste bad or prevent you from eating, but it usually lowers appetite and helps many people eat less without constant hunger. What matters here is that individual responses to these drugs can change over time. Clinical trials for semaglutide showed that many people lose substantial weight in the first months, and some reach a plateau where weight loss slows or stops. The Reddit post is a single-person report — an anecdote, not a study. It doesn’t tell us about their exact medical history, other medications, diet, activity level, or whether their doctor recommended a dose change. In clinical practice, doctors sometimes adjust the dose based on how a patient is doing, but decisions are individualized and guided by treatment guidelines and tolerability. For someone taking Wegovy, this situation is common enough to bring up with your prescriber. If you’re not losing more weight but aren’t gaining, that could be a stable maintenance phase — which might be fine if your health goals or markers have improved. Alternatively, a dose increase or changes in lifestyle support could be considered if you and your clinician decide more weight loss is safe and desirable. People who care about this are those using semaglutide for weight management, healthcare providers, and anyone planning to start the drug. There are important caveats. Only a qualified clinician should change your dose or stop/start any prescription. Semaglutide can cause side effects like nausea, vomiting, diarrhea, constipation, or rare but serious issues such as pancreatitis (inflammation of the pancreas). It’s also not suitable for people with certain medical histories, like a personal or family history of a rare type of thyroid cancer. Insurance coverage and the official dosing schedule also influence what doses are available. Finally, a single Reddit comment is not medical evidence — it’s a starting point for a conversation with your doctor. Bottom line: If your weight loss has stalled on Wegovy 1.7 mg, talk to your healthcare provider — they can review reasons for the plateau and decide whether a dose change, lifestyle adjustments, or other steps are right for you.
Source: r/Semaglutide